ReviewCancers (Basel)2026

Efficacy and Safety of Daraxonrasib (RMC-6236) in Previously Treated Metastatic RAS-Mutated Pancreatic Ductal Adenocarcinoma: A Systematic Review

DOI 10.3390/cancers18193112 ↗ OpenAlex, retrieved 5 November 2026

Journal: Cancers (Basel)
Published: 25 September 2026
Citations: 0
Type: Review

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try